376 related articles for article (PubMed ID: 22426476)
1. Activation of the Wnt/β-catenin signaling pathway is associated with glial proliferation in the adult spinal cord of ALS transgenic mice.
Chen Y; Guan Y; Liu H; Wu X; Yu L; Wang S; Zhao C; Du H; Wang X
Biochem Biophys Res Commun; 2012 Apr; 420(2):397-403. PubMed ID: 22426476
[TBL] [Abstract][Full Text] [Related]
2. Wnt signaling pathway is involved in the pathogenesis of amyotrophic lateral sclerosis in adult transgenic mice.
Chen Y; Guan Y; Zhang Z; Liu H; Wang S; Yu L; Wu X; Wang X
Neurol Res; 2012 May; 34(4):390-9. PubMed ID: 22643084
[TBL] [Abstract][Full Text] [Related]
3. Loss of glial fibrillary acidic protein marginally accelerates disease progression in a SOD1(H46R) transgenic mouse model of ALS.
Yoshii Y; Otomo A; Pan L; Ohtsuka M; Hadano S
Neurosci Res; 2011 Jul; 70(3):321-9. PubMed ID: 21453731
[TBL] [Abstract][Full Text] [Related]
4. An astrocyte regenerative response from vimentin-containing cells in the spinal cord of amyotrophic lateral sclerosis's disease-like transgenic (G93A SOD1) mice.
Zhou Y; Lu Y; Fang X; Zhang J; Li J; Li S; Deng X; Yu Y; Xu R
Neurodegener Dis; 2015; 15(1):1-12. PubMed ID: 25591625
[TBL] [Abstract][Full Text] [Related]
5. Wnt Signaling is altered by spinal cord neuronal dysfunction in amyotrophic lateral sclerosis transgenic mice.
Yu L; Guan Y; Wu X; Chen Y; Liu Z; Du H; Wang X
Neurochem Res; 2013 Sep; 38(9):1904-13. PubMed ID: 23784673
[TBL] [Abstract][Full Text] [Related]
6. Altered distribution and levels of cathepsinD and cystatins in amyotrophic lateral sclerosis transgenic mice: possible roles in motor neuron survival.
Wootz H; Weber E; Korhonen L; Lindholm D
Neuroscience; 2006 Dec; 143(2):419-30. PubMed ID: 16973300
[TBL] [Abstract][Full Text] [Related]
7. The mechanism of the WNT5A and FZD4 receptor mediated WNT/β-catenin pathway in the degeneration of ALS spinal cord motor neurons.
Jiang X; Liu J; Guan Y; Zhao Z; Meng F; Wang X; Gao X; Zhou F; Chen Y; Wang X
Biochem Biophys Res Commun; 2022 Jun; 609():23-30. PubMed ID: 35413536
[TBL] [Abstract][Full Text] [Related]
8. Expression of Wnt5a and its receptor Fzd2 is changed in the spinal cord of adult amyotrophic lateral sclerosis transgenic mice.
Li X; Guan Y; Chen Y; Zhang C; Shi C; Zhou F; Yu L; Juan J; Wang X
Int J Clin Exp Pathol; 2013; 6(7):1245-60. PubMed ID: 23826406
[TBL] [Abstract][Full Text] [Related]
9. Impaired response of hypoxic sensor protein HIF-1α and its downstream proteins in the spinal motor neurons of ALS model mice.
Sato K; Morimoto N; Kurata T; Mimoto T; Miyazaki K; Ikeda Y; Abe K
Brain Res; 2012 Sep; 1473():55-62. PubMed ID: 22871270
[TBL] [Abstract][Full Text] [Related]
10. Expression of the ALS-causing variant hSOD1(G93A) leads to an impaired integrity and altered regulation of claudin-5 expression in an in vitro blood-spinal cord barrier model.
Meister S; Storck SE; Hameister E; Behl C; Weggen S; Clement AM; Pietrzik CU
J Cereb Blood Flow Metab; 2015 Jul; 35(7):1112-21. PubMed ID: 25853911
[TBL] [Abstract][Full Text] [Related]
11. Activation transcription factor-3 activation and the development of spinal cord degeneration in a rat model of amyotrophic lateral sclerosis.
Malaspina A; Ngoh SF; Ward RE; Hall JC; Tai FW; Yip PK; Jones C; Jokic N; Averill SA; Michael-Titus AT; Priestley JV
Neuroscience; 2010 Aug; 169(2):812-27. PubMed ID: 20470869
[TBL] [Abstract][Full Text] [Related]
12. AIF translocates to the nucleus in the spinal motor neurons in a mouse model of ALS.
Oh YK; Shin KS; Kang SJ
Neurosci Lett; 2006 Oct; 406(3):205-10. PubMed ID: 16916579
[TBL] [Abstract][Full Text] [Related]
13. DREAM-Dependent Activation of Astrocytes in Amyotrophic Lateral Sclerosis.
Larrodé P; Calvo AC; Moreno-Martínez L; de la Torre M; Moreno-García L; Molina N; Castiella T; Iñiguez C; Pascual LF; Mena FJM; Zaragoza P; Y Cajal SR; Osta R
Mol Neurobiol; 2018 Jan; 55(1):1-12. PubMed ID: 28840473
[TBL] [Abstract][Full Text] [Related]
14. Astrocyte-derived Jagged-1 mitigates deleterious Notch signaling in amyotrophic lateral sclerosis.
Nonneman A; Criem N; Lewandowski SA; Nuyts R; Thal DR; Pfrieger FW; Ravits J; Van Damme P; Zwijsen A; Van Den Bosch L; Robberecht W
Neurobiol Dis; 2018 Nov; 119():26-40. PubMed ID: 30010003
[TBL] [Abstract][Full Text] [Related]
15. Effect of thymic stimulation of CD4+ T cell expansion on disease onset and progression in mutant SOD1 mice.
Sheean RK; Weston RH; Perera ND; D'Amico A; Nutt SL; Turner BJ
J Neuroinflammation; 2015 Feb; 12():40. PubMed ID: 25889790
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of metallothionein-I, a copper-regulating protein, attenuates intracellular copper dyshomeostasis and extends lifespan in a mouse model of amyotrophic lateral sclerosis caused by mutant superoxide dismutase-1.
Tokuda E; Okawa E; Watanabe S; Ono S
Hum Mol Genet; 2014 Mar; 23(5):1271-85. PubMed ID: 24163136
[TBL] [Abstract][Full Text] [Related]
17. TDP-43 expression in mouse models of amyotrophic lateral sclerosis and spinal muscular atrophy.
Turner BJ; Bäumer D; Parkinson NJ; Scaber J; Ansorge O; Talbot K
BMC Neurosci; 2008 Oct; 9():104. PubMed ID: 18957104
[TBL] [Abstract][Full Text] [Related]
18. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
[TBL] [Abstract][Full Text] [Related]
19. Progressive loss of a glial potassium channel (KCNJ10) in the spinal cord of the SOD1 (G93A) transgenic mouse model of amyotrophic lateral sclerosis.
Kaiser M; Maletzki I; Hülsmann S; Holtmann B; Schulz-Schaeffer W; Kirchhoff F; Bähr M; Neusch C
J Neurochem; 2006 Nov; 99(3):900-12. PubMed ID: 16925593
[TBL] [Abstract][Full Text] [Related]
20. Spinal inhibitory interneuron pathology follows motor neuron degeneration independent of glial mutant superoxide dismutase 1 expression in SOD1-ALS mice.
Hossaini M; Cardona Cano S; van Dis V; Haasdijk ED; Hoogenraad CC; Holstege JC; Jaarsma D
J Neuropathol Exp Neurol; 2011 Aug; 70(8):662-77. PubMed ID: 21760539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
